Assignee
GRIFOLS DIAGNOSTIC SOLUTIONS INC
US·5 granted patents·15 pending applications·1 citations·filing 2015–2024
Top patents by PatentIndex Score
20 records- 0176US2024344114A1Dual quenching assay for multiplex detection of target nucleic acidsGRIFOLS DIAGNOSTIC SOLUTIONS INC·Filed 2024·Application pending·0 cites
- 0276US2024336955A1Dual quenching assay for multiplex detection of target nucleic acidsGRIFOLS DIAGNOSTIC SOLUTIONS INC·Filed 2024·Application pending·0 cites
- 0372US11708418B2Compositions, methods and/or kits comprising a recombinant human CD38- extracellular domainGRIFOLS DIAGNOSTIC SOLUTIONS INC·Filed 2018·Granted Jul 25, 2023·1 cites·24 claims
- 0471US2024092929A1Compositions, methods and/or kits comprising a recombinant human cd38-extracellular domainGRIFOLS DIAGNOSTIC SOLUTIONS INC·Filed 2023·Application pending·0 cites
- 0569US2024228651A9Compositions, methods and/or kits comprising a recombinant human cd38-extracellular domainGRIFOLS DIAGNOSTIC SOLUTIONS INC·Filed 2023·Application pending·0 cites
- 0663US2024124549A1Immunoassays and engineered proteins for monitoring antibody treatments to the immune checkpoint inhibitors pd1 and pd-l1GRIFOLS DIAGNOSTIC SOLUTIONS INC·Filed 2023·Application pending·0 cites
- 0759US2022003789A1Device and method for detecting blood group antigens by means of an incomplete antibodyGRIFOLS DIAGNOSTIC SOLUTIONS INC·Filed 2021·Application pending·0 cites
- 0856US11746140B2Composition comprising recombinant GPlbα receptor proteinGRIFOLS DIAGNOSTIC SOLUTIONS INC·Filed 2019·Granted Sep 5, 2023·0 cites·26 claims
- 0956US11242571B2Method to homogenize parvovirus B19 in clinical samplesGRIFOLS DIAGNOSTIC SOLUTIONS INC·Filed 2019·Granted Feb 8, 2022·0 cites·32 claims
- 1054US2024209461A1Compositions and methods for storing a biological sampleGRIFOLS DIAGNOSTIC SOLUTIONS INC·Filed 2022·Application pending·0 cites
- 1153US2023220499A1Methods and compositions for detecting sars-cov-2 nucleic acidGRIFOLS DIAGNOSTIC SOLUTIONS INC·Filed 2021·Application pending·0 cites
- 1252US11919938B2Immunoassays and engineered proteins for monitoring antibody treatments to the immune checkpoint inhibitors PD1 and PD-L1GRIFOLS DIAGNOSTIC SOLUTIONS INC·Filed 2018·Granted Mar 5, 2024·0 cites·7 claims
- 1352US2022064585A1Device for breaking cellsGRIFOLS DIAGNOSTIC SOLUTIONS INC·Filed 2020·Application pending·0 cites
- 1445US11169160B2Device and method for detecting blood group antigens by means of an incomplete antibodyGRIFOLS DIAGNOSTIC SOLUTIONS INC·Filed 2015·Granted Nov 9, 2021·0 cites·17 claims
- 1545US2024270795A1Fusion proteins comprising sars-cov-2 receptor binding domainGRIFOLS DIAGNOSTIC SOLUTIONS INC·Filed 2021·Application pending·0 cites
- 1643US2024400618A1Fusion proteins comprising sars-cov-2 spike protein or the receptor thereofGRIFOLS DIAGNOSTIC SOLUTIONS INC·Filed 2021·Application pending·0 cites
- 1743US2023303629A1Fusion proteins comprising sars-cov-2 nucleocapsid domainsGRIFOLS DIAGNOSTIC SOLUTIONS INC·Filed 2021·Application pending·0 cites
- 1839US2021356481A1Systems and methods for biological sample laboratory screeningGRIFOLS DIAGNOSTIC SOLUTIONS INC·Filed 2018·Application pending·0 cites
- 1937US2021179668A1Novel mammalian expressed human immunodeficiency virus envelope protein antigensGRIFOLS DIAGNOSTIC SOLUTIONS INC·Filed 2018·Application pending·0 cites
- 2037US2024239876A1Anti-human immunodeficiency virus-1 antibodies and methods for uses thereofGRIFOLS DIAGNOSTIC SOLUTIONS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GRIFOLS DIAGNOSTIC SOLUTIONS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →